吲哚美辛水凝胶贴剂小鼠体外透皮性能研究

目的：通过研究不同促透剂对吲哚关辛水凝胶贴剂透皮性能的影响,遴选在特定栽药剂量时具有最佳促透效果的促透剂,并与市售贴剂进行比较,对吲哚美辛水凝胶贴剂的体外透皮性能进行评价。方法：采用改良Franz透皮扩散池,以离体小鼠背部皮肤为透皮屏障,在最佳载药量选用不同浓度的氮酮、油酸、丙二醇以及三者组成的二元或三元组合为促透剂,在规定时间点测定吲哚美辛的累积透过百分率以及单位面积累积透过量。结果：与空白对照组相比,当氮酮与油酸单独应用时,二者均没有明显的促透作用;当选用二元促透剂联合应用时,油酸与丙二醇联用能够明显促进吲哚美辛的经皮渗透（P〈0．05）;当选用三元促透剂时促透效果更好,单位面积累积透过量最高可达234．4μg·cm^-2,24h内药物累积透过百分率明显高于市售贴剂。结论：氮酮、油酸、丙二醇三者联合应用可作为吲哚关辛贴剂的理想促透剂。吲哚关辛水凝胶贴剂是具有应用价值的新型经皮控释制剂。     

正交实验优化川陈皮素微乳凝胶剂促渗剂及体外释药评价

本文筛选了川陈皮素微乳凝胶剂的最佳透皮促渗剂并考察了其体外释药机制。采用正交实验设计,对离体家兔鼻粘膜进行体外渗透实验,以川陈皮素的累积渗透量及渗透速率常数为指标,优选最佳处方;采用扩散池法对川陈皮素微乳凝胶剂进行体外释药研究,并用无膜溶出法考察其释药机制。结果表明,不同促渗剂对川陈皮素的累积渗透量及渗透速率常数影响大小为:氮酮冰片丙二醇,且氮酮具有显著性差异(P0.05),微乳凝胶剂12 h的累积释药率为86%,符合Higuchi方程,其溶蚀量较少且与释药率无明显线性相关(r=0.9387)。可见,2%氮酮、2%冰片和1%丙二醇可作为最佳促渗剂处方在川陈皮素微乳凝胶剂中使用,且该制剂体外释药性能良好,有一定的缓释特性。     

王不留行黄酮苷软膏剂体外透皮吸收研究

为了研究渗透吸收促进剂氮酮用量对王不留行黄酮苷软膏剂体外经皮渗透性能的影响及为该化合物经皮给药系统的开发提供参考。本实验采用HPLC测定王不留行黄酮苷的含量,流动相为甲醇和水,检测波长280 nm。选取大鼠背部皮肤,通过Franz垂直扩散池考察王不留行黄酮苷软膏剂透皮性能,结果表明24 h内,不同浓度的氮酮对王不留行黄酮苷软膏剂透皮吸收均有一定的促进作用,其促渗作用为1%氮酮0.5%氮酮5%氮酮3%氮酮0%氮酮。本实验说明氮酮能促进王不留行黄酮苷软膏剂中的王不留行黄酮苷透皮吸收,以1%的氮酮促透效果最佳。     

离子导入法和渗透促进剂并用对裸鼠皮肤角质层影响的ESR研究

通过测定５－唑烷氮氧自由基硬脂酸（５－ＤＳＡ）标记裸鼠皮肤角质层的ＥＳＲ谱,研究离子导入法与渗透促进剂１００％月桂氮酮（１００％ＡＺ）、５％月桂氨　酮／丙二醇溶液（５％　ＡＺ／ＰＧ）和１０％油酸／丙二醇溶液（１０％ＯＡ／ＰＧ）并用对裸鼠皮肤角质层的影响。离子导入法处理皮肤后,标记物序参数降低,各向同性超精细分裂偶合常数增大,表明低密度电流能够引起皮肤角质层细胞间脂质排列有序性降低,流动性增大,极性增大;离子导入法与渗透促进剂并用处理皮肤后,序参数进一步降低,各向同性超精细分裂偶合常数进一步增大,表明二者对皮肤角质层的影响具有协同作用。     

多糖对滇紫草培养细胞的影响

黑节草多糖、火棘果果胶和琼脂加入到培养基中,均能促进滇紫草细胞合成紫草素。黑节草多糖促进紫草素合成的最适浓度为0.05—0.1％,大于最适浓度紫草素合成逐渐受到抑制。三种黑节草多糖单体中以多糖Ⅱ最为有效,紫草素产量为90.07mg/l。加入火棘果果胶和琼脂均对紫草素合成呈现促进作用。最后对多糖的作用机理以及多糖与寡糖的关系进行了讨论。     

紫草素抑制破骨细胞分化及改善去卵巢诱导的小鼠骨质疏松

目的:研究紫草素对破骨细胞体外分化的影响,并探讨其对去卵巢(ovariectomized,OVX)诱导的骨质疏松模型小鼠的骨保护作用。方法:体外细胞生物学实验,采用CCK-8法检测不同浓度紫草素对C57BL/6J小鼠骨髓源性单核巨噬细胞的毒性;采用RANKL和M-CSF诱导单核巨噬细胞破骨分化模型,给予不同浓度的紫草素干预后,经TRAP染色对破骨细胞进行形态学观察,并通过Real-Time PCR技术检测破骨细胞特异性基因TRAP、c-Fos和NFATc1的表达。动物体内实验,随机将15只小鼠平均分为假手术组、OVX组、治疗组。造模成功后治疗组给予紫草素干预,假手术组和OVX组以等体积生理盐水处理。连续处理30天后取胫骨,用Micro CT扫描重建观察胫骨近端骨丢失状况。结果:(1)高于250 nmol/L的紫草素显著抑制小鼠单核巨噬细胞生长(P0.01)。(2)不同浓度的紫草素干预能显著抑制体外破骨细胞形成(P0.01)。(3)不同浓度的紫草素干预能显著抑制TRAP,c-Fos和NFATc1等参与破骨细胞分化的重要基因表达(P0.01)。(4)紫草素干预能显著改善去卵巢诱导的骨质疏松模型小鼠的骨丢失(P0.05)。结论:紫草素能在体外抑制破骨细胞分化并在体内改善去卵巢诱导的小鼠骨质疏松。     

紫草素对人肝癌HepG2细胞增殖的抑制及诱导凋亡作用

目的:观察紫草素抑制人肝癌HepG2细胞增殖及凋亡诱导的作用。方法:用不同浓度的紫草素处理HepG2细胞,MTT检测紫草素对HepG2细胞生长增殖的抑制作用;比色法测定Caspase-3酶活性;Western blot法检测磷酸化Akt蛋白(pAkt)的表达。结果:紫草素能够抑制人肝癌HepG2细胞的增殖,并呈浓度、时间依赖性,紫草素与HepG2细胞作用24小时后Caspase-3酶活性显著增强,显示紫草素诱导的调亡作用随时间的延长而增加;同时,紫草素处理HepG2细胞后,随着药物浓度的增加,磷酸化Akt蛋白表达下降。结论:紫草素可抑制人肝癌细胞HepG2的增殖,诱导HepG2细胞凋亡,凋亡机制可能与紫草素抑制PI3K/Akt信号途径有关。     

紫草素通过下调HPV E6/E7蛋白表达抑制宫颈癌Caski细胞增殖

宫颈癌是发展中国家癌症死亡的主要癌症之一,也是最常见的女性生殖系统肿瘤,它与病毒相关且其主要是由人乳头瘤病毒(human papillomavirus, HPV)感染引起的癌症。紫草素在控制细胞凋亡、坏死性凋亡和免疫原性细胞死亡中的重要作用而被证明具有抗肿瘤活性,且与肿瘤细胞生长和转移密切相关,但是缺乏相应的机理和机制研究。因此本实验就通过用不同浓度紫草素处理宫颈癌细胞来研究紫草素的作用机理。结果表明,紫草素能够通过下调HPV E6/E7蛋白的表达,从而提高抑癌因子P53的活性,以促进宫颈癌细胞凋亡的发生。且与前人的研究相同的是,HPV E6/E7蛋白低表达不利于宫颈癌细胞的增殖和迁移。因此,这些结果充分证实了紫草素能有效地抑制宫颈癌细胞增殖和迁移,以及促进癌细胞凋亡的作用。本实验的研究结果探索了紫草素抑制肿瘤的机制,并为宫颈癌治疗的新方法提供了新的思路以及为后续机制的研究提供了参考和理论依据。     

滇紫草愈伤组织培养与紫草素产生

浓度为10~(-5)Smol/1和10~(-6)mol/l的2,4-D和NAA分别与10~(-5)mol/l的KT组合,能明显抑制滇紫草(Onosma paniculatum Bur. et Fr.)愈伤组织中紫草素的产生,但几乎不受天然生长素IAA和KT组合的影响。葡萄糖较蔗糖能更有效地促进紫草素的产生,它们的最适浓度均为6％。LH和CH能抑制紫草素的产生,CH浓度大于0.02％时能抑制愈伤组织的生长,LH对生长无明显影响。椰乳浓度为10％时,能明显地促进紫草素的产生,紫草素的含量是对照的24倍。     

紫草素对白色念珠菌的抑制作用机制

【目的】研究紫草素抑制白色念珠菌的作用机制。【方法】通过微量稀释法测定紫草素对白色念珠菌的最低抑菌浓度(MIC)和最低杀菌浓度(MFC);紫外分光光度法测定紫草素对白色念珠菌细胞膜渗透性的影响;扫描电镜观察紫草素对菌体形态的影响;激光共聚焦显微镜测定紫草素对白色念珠菌细胞内钙离子浓度的影响;卵黄平板培养基法检测紫草素对白色念珠菌的细胞膜磷脂酶活性的影响;RT-PCR检测紫草素对白色念珠菌PLB1和PLB2基因表达量的影响。【结果】紫草素对白色念珠菌有较强的抑制作用,其对白色念珠菌的MIC和MFC分别为16μg/m L和32μg/mL。紫草素能破坏白色念珠菌细胞膜的完整性,使细胞膜的通透性增加,导致细胞内DNA和RNA等大分子物质的泄漏和细胞内钙离子的流失。其中MIC的紫草素作用菌体16 h后,上清液中的DNA和RNA等大分子含量与对照组相比增加了117.32%(P0.01);细胞内的[Ca~(2+)]降低了72.02%(P0.01)。扫描电镜结果也证明了紫草素对白色念珠菌细胞膜的破坏作用。紫草素也能抑制白色念珠菌分泌磷脂酶,且呈浓度剂量依赖。其中,与对照组相比,MIC的紫草素能使白色念珠菌分泌磷脂酶的量下降56.3%(P0.01)。RT-PCR结果显示,紫草素能抑制编码磷脂酶B的基因PLB1和PLB2的表达量,其中1/2 MIC的紫草素作用白色念珠菌16 h后,与对照组相比,PLB1和PLB2基因的相对表达量分别降低了56.4%和61.4%(P0.01)。【结论】紫草素对白色念珠菌有较强的抑杀作用,其作用机制是通过破坏白色念珠菌细胞膜的完整性,增加菌体细胞膜的通透性,导致细胞内DNA和RNA等大分子的泄漏和细胞内[Ca~(2+)]的流失,最终引起菌体的死亡。而紫草素对白色念珠菌磷脂酶分泌的抑制作用,致使其不能及时维护和修复由紫草素造成的细胞膜的破坏和损伤,也是导致菌体死亡的原因。     

The Enhancing Effect of Ion-pairing on the Skin Permeation of Glipizide

The purpose of the present study was to investigate the permeation of glipizide (GP) and observe the effect of an interaction with amines as counter ions, including diethylamine, triethylamine, ethanolamine, diethanolamine, triethanolamine, N-(2-hydroxylethyl) piperidine. Permeation experiments were performed in vitro, using rat abdominal skin as a barrier. The lipophilic donor system consisting of isopropyl myristate (IPM) and ethanol (EtOH; EI system, 8:2) produced a marked enhancement of GP flux through rat skin. All the amines investigated in this study had performed an enhancing effect on GP flux, and triethylamine had the most potent enhancing effect on GP in the vehicle IPM:EtOH = 8:2(w/w). In the presence of counter ions, the solubility of GP in the donor solution (IPM:EtOH = 8:2) was increased and the log K_o/w of GP was decreased, which may due to higher solubility of the GP in the IPM:EtOH = 8:2(w/w). ¹³C NMR spectroscopy was used to identify the ion-pairing formation between GP and the respective counter ion. It was surprising that all the four enhancers examined, such as isopropyl myristate, propylene glycol, N-methyl-2-pyrrolidone, azone, and oleic acid, had no enhancing effect on the percutaneous permeation of GP. This study showed that the formation of ion-pairs between GP and counter ions is a useful method to promote the skin permeation of GP.Key words: amine, counter ion, glipizide, ion-pair, percutaneous absorption     

A Preformulation Strategy for the Selection of Penetration Enhancers for a Transungual Formulation

Onychomycosis is associated with the cutaneous fungal infection of the nail and the nail folds (skin surrounding the nail). It is therefore important to target drug delivery into the nail folds along with nail plate and the nail bed. Systematic and strategic selection of the penetration enhancers specific for the skin and the nail is discussed. Twelve penetration enhancers were screened for their ability to improve solubility, in vitro nail penetration, in vitro skin permeation, and in vitro skin penetration of the antifungal drug ciclopirox olamine. In contrast to transdermal drug delivery, the main selection criteria for skin penetration enhancer in topical drug delivery were increased drug accumulation in the epidermis and minimal permeation across the skin. Thiourea improved the solubility and nail penetration of ciclopirox olamine. It also showed enhancement in the transungual diffusion of the drug. Propylene glycol showed a 12-fold increase in solubility and 3-fold increase in epidermal accumulation of ciclopirox olamine, while minimizing the transdermal movement of the drug. Thiourea was the selected nail permeation enhancer and propylene glycol was the selected skin penetration enhancer of ciclopirox olamine. A combination of the selected enhancers was also explored for its effect on drug delivery to the nail and nail folds. The enhancer combination reduced the penetration of ciclopirox in the skin and also the permeation through the nail. The proposed preformulation strategy helps to select appropriate enhancers for optimum topical delivery and paves way towards an efficient topical formulation for passive transungual drug delivery.     

Development and Evaluation of Ethyl Cellulose-Based Transdermal Films of Furosemide for Improved In Vitro Skin Permeation

Transdermal films of the furosemide were developed employing ethyl cellulose and hydroxypropyl methylcellulose as film formers. The effect of binary mixture of polymers and penetration enhancers on physicochemical parameters including thickness, moisture content, moisture uptake, drug content, drug–polymer interaction, and in vitro permeation was evaluated. In vitro permeation study was conducted using human cadaver skin as penetration barrier in modified Keshary–Chein diffusion cell. In vitro skin permeation study showed that binary mixture, ethyl cellulose (EC)/hydroxypropyl methylcellulose (HPMC), at 8.5:1.5 ratio provided highest flux and also penetration enhancers further enhanced the permeation of drug, while propylene glycol showing higher enhancing effect compared to dimethyl sulfoxide and isopropyl myristate. Different kinetic models, used to interpret the release kinetics and mechanism, indicated that release from all formulations followed apparent zero-order kinetics and non-Fickian diffusion transport except formulation without HPMC which followed Fickian diffusion transport. Stability studies conducted as per International Conference on Harmonization guidelines did not show any degradation of drug. Based on the above observations, it can be reasonably concluded that blend of EC–HPMC polymers and propylene glycol are better suited for the development of transdermal delivery system of furosemide.     

Feasibility of transdermal delivery of fluoxetine

Feasibility of developing a transdermal drug delivery of fluoxetine has been investigated. Permeation studies of fluoxetine across human cadaver skin were carried out using Franz diffusion cells. The receptor phase consisted of pH 7.4 phosphate buffer maintained at 37°C. Permeation enhancement of fluoxetine, either in the salt or base form, was achieved using various enhancers like azone, SR-38, and ethanol. Various O/W microemulsion systems of fluoxetine were developed to study their effect on the skin permeation of fluoxetine. The results indicated that ethanol at 65% vol/vol was able to increase the permeation of fluoxetine the most, while microemulsion systems showed decrease in the permeation of fluoxetine. The permeation of fluoxetine obtained using a 65% vol/vol ethanolic solution was found to be sufficient to deliver the required dose (20–80 mg) from a patch of feasible size. The results seem promising for developing a transdermal drug delivery system of fluoxetine. Published: September 30, 2005     

Propylene Glycol Liposomes as a Topical Delivery System for Miconazole Nitrate: Comparison with Conventional Liposomes

Propylene glycol (PG)-phospholipid vesicles have been advocated as flexible lipid vesicles for enhanced skin delivery of drugs. To further characterize the performance of these vesicles and to address some relevant pharmaceutical issues, miconazole nitrate(MN)-loaded PG nanoliposomes were prepared and characterized for vesicle size, entrapment efficiency, in vitro release, and vesicle stability. An issue of pharmaceutical importance is the time-dependent, dilution-driven diffusion of propylene glycol out of the vesicles. This was addressed by assessing propylene glycol using gas chromatography in the separated vesicles and monitoring its buildup in the medium after repeated dispersion of separated vesicles in fresh medium. Further, the antifungal activity of liposomal formulations under study was assessed using Candida albicans, and their in vitro skin permeation and retention were studied using human skin. At all instances, blank and drug-loaded conventional liposomes were included for comparison. The results provided evidence of controlled MN delivery, constant percent PG uptake in the vesicles (≈45.5%) in the PG concentration range 2.5 to 10%, improved vesicle stability, and enhanced skin deposition of MN with minimum skin permeation. These are key issues for different formulation and performance aspects of propylene glycol-phospholipid vesicles.     

<Emphasis Type="Italic">In vitro</Emphasis> Enhancement of Lactate Esters on the Percutaneous Penetration of Drugs with Different Lipophilicity

Lactate esters are widely used as food additives, perfume materials, medicine additives, and personal care products. The objective of this work was to investigate the effect of a series of lactate esters as penetration enhancers on the in vitro skin permeation of four drugs with different physicochemical properties, including ibuprofen, salicylic acid, dexamethasone and 5-fluorouracil. The saturated donor solutions of the evaluated drugs in propylene glycol were used in order to keep a constant driving force with maximum thermodynamic activity. The permeability coefficient (K _p), skin concentration of drugs (SC), and lag time (T), as well as the enhancement ratios for K _p and SC were recorded. All results indicated that lactate esters can exert a significant influence on the transdermal delivery of the model drugs and there is a structure-activity relationship between the tested lactate esters and their enhancement effects. The results also suggested that the lactate esters with the chain length of fatty alcohol moieties of 10–12 are more effective enhancers. Furthermore, the enhancement effect of lactate esters increases with a decrease of the drug lipophilicity, which suggests that they may be more efficient at enhancing the penetration of hydrophilic drugs than lipophilic drugs. The influence of the concentration of lactate esters was evaluated and the optimal concentration is in the range of 5∼10 wt.%. In sum, lactate esters as a penetration enhancer for some drugs are of interest for transdermal administration when the safety of penetration enhancers is a prime consideration.     

Development and Evaluation of α-Asarone Transdermal Patches Based on Hot-Melt Pressure-Sensitive Adhesives

A hot-melt, pressure-sensitive adhesive (HMPSA) based on styrene–isoprene–styrene was prepared, and its compatibility with various transdermal penetration enhancers was investigated. The effect of penetration enhancers on the adhesion properties of HMPSA was also studied. A drug-in-adhesive patch was formulated using α-asarone as a model drug, and penetration enhancers were screened by an in vitro transdermal study across excised pig skin. The pharmacokinetics in rabbits was also studied. The results show that HMPSA was miscible with most penetration enhancers (azone, menthol, isopropyl myristate, 1-methyl-pyrrolidinone, N,N-dimethylformamide, oleic acid), apart from propylene glycol. Penetration enhancers had a plasticizer-like effect that decreased the peel strength and shear strength of HMPSA. A combination of 1% oleic acid and 4% menthol had the highest in vitro penetration rate and was selected for patch preparation. The patch formulation was optimized by replacing some of the plasticizer by penetration enhancers to achieve good adhesion and effective transdermal flux. The final patch showed a high efficiency, with a relative bioavailability of 1,494%. This suggests that HMPSA may be a promising material for drug-delivery patches.     

Transdermal Permeation of Kaempferia parviflora Methoxyflavones from Isopropyl Myristate-Based Vehicles

Kaempferia parviflora (K. parviflora) rhizomes have long been used in traditional folk medicines and as general health-promoting agents. Several biological activities of K. parviflora, especially its anti-inflammatory effect, are due to its major constituents, methoxyflavones. However, the oral bioavailability of these methoxyflavones has been shown to be low. The aim of this study was to investigate the permeation behaviors of K. parviflora methoxyflavones from isopropyl myristate (IPM)-based vehicles. We studied the effects of ethanol and propylene glycol (PG) as the hydrophilic, solvent-type vehicles as well as fatty acids as the permeation enhancers. A permeation experiment was performed in vitro, using side-by-side diffusion cells through the full thickness of pig ear skin. The solubility and permeation of methoxyflavones were able to be modified by choice and ratio of vehicles. The ethanol/IPM vehicle was shown to be more effective in enhancing the solubility and permeation of methoxyflavones when compared to the PG/IPM vehicle. Regarding an optimal balance between solubility or affinity to vehicle and skin to vehicle partition coefficient, the ethanol/IPM vehicle in the ratio of 1:9 maximized the flux. Among the investigated fatty acids, oleic acid showed the greatest enhancing effect on the permeation of methoxyflavones, indicating that saturated fatty acids are less effective than unsaturated fatty acids. Long chain fatty acids increased diffusion coefficient parameter and shortened the lag time. The number of carbon atoms and double bonds of fatty acids did not show direct relation to the profile of permeation of methoxyflavones.     

Using Raman Spectroscopy in Studying the Effect of Propylene Glycol,Oleic Acid,and Their Combination on the Rat Skin

The permeability enhancement effect of oleic acid (OA) and propylene glycol (PG) as well as their (1:1 v/v) combined mixture was studied using rat skin. The percutaneous drug administration is a challenge and an opportunity for drug delivery. To date, there is limited research that illustrates the mechanism of penetration enhancers and their combinations on the skin. This project aims to explore the skin diffusion and penetration enhancement of PG, OA, and a combination of PG-OA (1:1 v/v) on rat skin and to identify the potential synergistic effect of the two enhancers utilizing Raman spectroscopy. Dissected dorsal skin was treated with either PG or OA or their combination for predetermined time intervals after which the Raman spectra of the treated skin were collected with the enhancer. A spectrum of the wiped and the washed skin were also collected. The skin integrity was tested before and after exposure to PG. The skin histology proved that the skin integrity has been maintained during experiments and the results indicated that OA disrupted rat skin lipid as evident by changes in the lipid peak. The results also showed that PG and OA improved the diffusion of each other and created faster, yet reversible changes of the skin peaks. In conclusion, Raman spectroscopy is a potential tool for ex vivo skin diffusion studies. We also concluded that PG and OA have potential synergistic reversible effect on the skin.     

Microemulsion for topical delivery of fenoprofen calcium: in vitro and in vivo evaluation

The aim of this study was to investigate microemulsion (ME) based topical delivery system for fenoprofen calcium (FPCa) to eliminate its oral gastrointestinal adverse effects. ME was prepared by the water titration method using oleic acid as oil phase, tween 80 as a surfactant and propylene glycol as a cosurfactant. Oleic acid was selected as oil phase due to its good solubilizing capacity. ME existence region was determined using pseudo-ternary phase diagrams for preparing different formulations. Six different formulations were selected with various values of oil (25–68%), water (2–3%), and the mixture of surfactant and cosurfactant (1:1) (24–67%). The selected ME formulae were characterized for optical birefringence, transmission electron microscopy (TEM), pH, % transmittance, electronic conductivity, drug content, droplet size, rheological properties and stability evaluation. In vitro release study of FPCa from ME s through the synthetic membrane and hairless rat skin were evaluated. The optimized formula ME5 consisting of 5% w/w FPCa, 60% w/w oleic acid as oil phase, 3% w/w aqueous phase, and 32% w/w of surfactant phase containing Tween 80 and propylene glycol (1:?1) showed the highest transdermal flux and highest skin permeation rate. Finally, the % inhibition of carrageenan-induced rat paw edema of the optimized formula ME5 was highly significant (p?0.001) as compared to plain gel of FPCa. In conclusion, ME is a promising technique for topical delivery of FPCa.